Colleen Cutcliffe

Colleen Cutcliffe is the current CEO of Pendulum Therapeutics. Colleen has also previously worked with CLSI California Life Sciences Institute, Pacific Biosciences, and Elan Pharmaceuticals. Colleen has a passion for working with innovative technologies that have the potential to transform the way we understand biological systems. Her experience in developing and transferring assays to automated high throughput systems has been key in their success in identifying small molecules of interest which demonstrate the ability to enhance enzymatic activity.

Colleen Cutcliffe has a Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University. Colleen also has a BA in Biochemistry from Wellesley College. Colleen attended high school at The Westminster Schools in Atlanta, GA.

Orville Kolterman - Chief Medical Officer, John Eid - CSO, and Jim Bullard - CTO And Co-founder report to Colleen Cutcliffe.